Suraksha Diagnostic Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Suraksha Diagnostic Limited has informed the exchanges that the trading window for its securities will remain closed for all designated persons and their immediate relatives starting Wednesday, 1 April 2026. The closure will remain in effect until 48 hours after the company declares its audited standalone and consolidated financial results for the quarter and financial year ended 31 March 2026. This is done in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's own insider trading code. The date of the board meeting to approve the FY26 results has not yet been announced and will be communicated to the exchanges later. The intimation has been shared with all designated and connected persons.
This is a routine regulatory filing with no direct impact on the stock price. It signals that the company's FY26 annual results announcement is approaching, which investors should watch for. Designated insiders cannot trade in the stock during this blackout period.